Inquire About a Product| Product: | Goserelin Acetate | ||||
|---|---|---|---|---|---|
| Catalog Number: | 18874 | ||||
| CAS Number: | 145781-92-6 | ||||
| Synonyms: | (D-Ser(tBu)6,Azagly10)-LHRH acetate salt | ||||
| Pricing: |
|
||||
| Formula: | C59H84N18O14 | ||||
| Chemical Purity: | >99% | ||||
| Molecular Weight: | 1269.41 | ||||
| Structure: |
|
||||
| Appearance: | Powder | ||||
| Category: | Anti-cancer compounds | ||||
| Stability: | Stable under recommended storage conditions | ||||
| Storage: |
Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: -20°C |
||||
| Transportation: |
Non-hazardous for transport |
||||
| Literature References: |
Wells, A., et al., Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling. Clin. Cancer Res. 8, 1251-1257, (2002); Cook, T., and Sheridan, W.P., Development of GnRH antagonsts for prostate cancer: new approaches to treatment. Oncologist 5, 162-168, (2000); Spicer, D.V., and Pike, M.C., Future possibilities in the prevention of breast cancer: luteinizing hormone-releasing hormone agonists. Breast Cancer Res. Treat. 2, 264-267, (2000) |
||||
| MSDS: | |||||
| Description: |
Goserelin is a synthetic analog of LHRH (leutinizing hormone releasing hormone). Goserelin is a LHRH agonist It is used in prostate cancer and breast cancer therapies and also in the treatment of endometriosis |